Beyond unequal access: Acculturation, race, and resistance to pharmaceuticalization in the United States

Crystal Adams, Anwesa Chatterjee, Brittany M. Harder, Liza Hayes Mathias

Research output: Contribution to journalArticle

Abstract

Trends toward pharmaceuticalization in Western countries have led to increased research and theorizing about the roles macro-level institutions, structures, and collective actors play in contributing to patients’ reliance on prescription drugs. Relatively less work has focused on the degree to which patients resist pharmaceuticalization pressures, and even less research has explored the factors contributing to patients’ resistance to pharmaceuticalization. Drawing on focus groups with patients who had been recently prescribed a prescription drug, this paper investigates how marginalization in the mainstream US society, as measured by acculturation and race, contributes to differences in patients’ subjective experiences and responses to prescription drugs. We find that racial minorities report a greater skepticism of prescription drugs compared to whites and express that they turn to prescription drugs as a last resort. While highly acculturated participants rarely discuss alternatives to prescription drugs, less acculturated racial minorities indicate a preference for complementary and alternative remedies. We draw on the literatures on the pharmaceuticalization of society and the social nature of medicine to examine the role marginalization plays in patients’ views of prescription drugs. Public health research conceives of racial minorities’ lower rates of prescription drug usage compared to whites as primarily a problem of lack of access. Our results suggest another piece to the puzzle: minorities resist pharmaceuticalization pressures to express their cultural and racial identities.

Original languageEnglish (US)
Pages (from-to)350-357
Number of pages8
JournalSSM - Population Health
Volume4
DOIs
StatePublished - Apr 1 2018

Fingerprint

Acculturation
Prescription Drugs
acculturation
medication
drug
minority
Research
Pressure
role play
macro level
Focus Groups
remedies
Public Health
public health
Medicine
medicine
lack
trend

Keywords

  • Acculturation
  • Medical sociology
  • Prescription drugs
  • Race

ASJC Scopus subject areas

  • Health(social science)
  • Health Policy
  • Public Health, Environmental and Occupational Health

Cite this

Beyond unequal access : Acculturation, race, and resistance to pharmaceuticalization in the United States. / Adams, Crystal; Chatterjee, Anwesa; Harder, Brittany M.; Mathias, Liza Hayes.

In: SSM - Population Health, Vol. 4, 01.04.2018, p. 350-357.

Research output: Contribution to journalArticle

Adams, Crystal ; Chatterjee, Anwesa ; Harder, Brittany M. ; Mathias, Liza Hayes. / Beyond unequal access : Acculturation, race, and resistance to pharmaceuticalization in the United States. In: SSM - Population Health. 2018 ; Vol. 4. pp. 350-357.
@article{a30118d00cd24d008586778407c988e0,
title = "Beyond unequal access: Acculturation, race, and resistance to pharmaceuticalization in the United States",
abstract = "Trends toward pharmaceuticalization in Western countries have led to increased research and theorizing about the roles macro-level institutions, structures, and collective actors play in contributing to patients’ reliance on prescription drugs. Relatively less work has focused on the degree to which patients resist pharmaceuticalization pressures, and even less research has explored the factors contributing to patients’ resistance to pharmaceuticalization. Drawing on focus groups with patients who had been recently prescribed a prescription drug, this paper investigates how marginalization in the mainstream US society, as measured by acculturation and race, contributes to differences in patients’ subjective experiences and responses to prescription drugs. We find that racial minorities report a greater skepticism of prescription drugs compared to whites and express that they turn to prescription drugs as a last resort. While highly acculturated participants rarely discuss alternatives to prescription drugs, less acculturated racial minorities indicate a preference for complementary and alternative remedies. We draw on the literatures on the pharmaceuticalization of society and the social nature of medicine to examine the role marginalization plays in patients’ views of prescription drugs. Public health research conceives of racial minorities’ lower rates of prescription drug usage compared to whites as primarily a problem of lack of access. Our results suggest another piece to the puzzle: minorities resist pharmaceuticalization pressures to express their cultural and racial identities.",
keywords = "Acculturation, Medical sociology, Prescription drugs, Race",
author = "Crystal Adams and Anwesa Chatterjee and Harder, {Brittany M.} and Mathias, {Liza Hayes}",
year = "2018",
month = "4",
day = "1",
doi = "10.1016/j.ssmph.2018.04.003",
language = "English (US)",
volume = "4",
pages = "350--357",
journal = "SSM - Population Health",
issn = "2352-8273",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Beyond unequal access

T2 - Acculturation, race, and resistance to pharmaceuticalization in the United States

AU - Adams, Crystal

AU - Chatterjee, Anwesa

AU - Harder, Brittany M.

AU - Mathias, Liza Hayes

PY - 2018/4/1

Y1 - 2018/4/1

N2 - Trends toward pharmaceuticalization in Western countries have led to increased research and theorizing about the roles macro-level institutions, structures, and collective actors play in contributing to patients’ reliance on prescription drugs. Relatively less work has focused on the degree to which patients resist pharmaceuticalization pressures, and even less research has explored the factors contributing to patients’ resistance to pharmaceuticalization. Drawing on focus groups with patients who had been recently prescribed a prescription drug, this paper investigates how marginalization in the mainstream US society, as measured by acculturation and race, contributes to differences in patients’ subjective experiences and responses to prescription drugs. We find that racial minorities report a greater skepticism of prescription drugs compared to whites and express that they turn to prescription drugs as a last resort. While highly acculturated participants rarely discuss alternatives to prescription drugs, less acculturated racial minorities indicate a preference for complementary and alternative remedies. We draw on the literatures on the pharmaceuticalization of society and the social nature of medicine to examine the role marginalization plays in patients’ views of prescription drugs. Public health research conceives of racial minorities’ lower rates of prescription drug usage compared to whites as primarily a problem of lack of access. Our results suggest another piece to the puzzle: minorities resist pharmaceuticalization pressures to express their cultural and racial identities.

AB - Trends toward pharmaceuticalization in Western countries have led to increased research and theorizing about the roles macro-level institutions, structures, and collective actors play in contributing to patients’ reliance on prescription drugs. Relatively less work has focused on the degree to which patients resist pharmaceuticalization pressures, and even less research has explored the factors contributing to patients’ resistance to pharmaceuticalization. Drawing on focus groups with patients who had been recently prescribed a prescription drug, this paper investigates how marginalization in the mainstream US society, as measured by acculturation and race, contributes to differences in patients’ subjective experiences and responses to prescription drugs. We find that racial minorities report a greater skepticism of prescription drugs compared to whites and express that they turn to prescription drugs as a last resort. While highly acculturated participants rarely discuss alternatives to prescription drugs, less acculturated racial minorities indicate a preference for complementary and alternative remedies. We draw on the literatures on the pharmaceuticalization of society and the social nature of medicine to examine the role marginalization plays in patients’ views of prescription drugs. Public health research conceives of racial minorities’ lower rates of prescription drug usage compared to whites as primarily a problem of lack of access. Our results suggest another piece to the puzzle: minorities resist pharmaceuticalization pressures to express their cultural and racial identities.

KW - Acculturation

KW - Medical sociology

KW - Prescription drugs

KW - Race

UR - http://www.scopus.com/inward/record.url?scp=85045659373&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85045659373&partnerID=8YFLogxK

U2 - 10.1016/j.ssmph.2018.04.003

DO - 10.1016/j.ssmph.2018.04.003

M3 - Article

AN - SCOPUS:85045659373

VL - 4

SP - 350

EP - 357

JO - SSM - Population Health

JF - SSM - Population Health

SN - 2352-8273

ER -